$COLL COLLEGIUM PHARMACEUTICAL, INC Insider Trading
Get free email notifications about insider trading in COLLEGIUM PHARMACEUTICAL, INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in COLLEGIUM PHARMACEUTICAL, INC. Insider overview, share value development, latest insider transactions and email notifications about new events in COLLEGIUM PHARMACEUTICAL, INC for free.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: COLL
Company Address: 100 TECHNOLOGY CENTER DRIVE STOUGHTON 02072
Phone number: 781-713-3699
Former name: COLLEGIUM PHARMACEUTICAL INC, date of change: 2003-10-20
Collegium Pharmaceutical, Inc. operates as a pharmaceutical company. The firm engages in the development and planning to commercialize next generation, abuse-deterrent products for the treatment of patients suffering from chronic pain and other diseases. Its products include Xtampza ER, Nucynta ER and Nucynta IR. The Xtampza ER provides pain control while maintaining its extended-release drug release profile after being subjected to common methods of abuse and accidental misuse. The Nucynta ER for the treatment of chronic pain and neuropathic pain associated with diabetic peripheral neuropathy. The Nucynta IR is a release formulation of tapentadol indicated for the management of acute pain severe enough to require an opioid analgesic. The company was founded by Michael Thomas Heffernan in April 2002 and is headquartered in Stoughton, MA.
Market Capitalization: $351.67M
Prev close: $15.36
Average Daily Volume: 226,161
Days Low: $14.72
Year Low: $8.24
Year High: $21.45
COLLEGIUM PHARMACEUTICAL, INC Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 24 2021 | COLL | COLLEGIUM PHARMACE ... | Freund John Gordon | Director | Grant | A | 0.00 | 9,941 | 0 | 20,948 | 11 K to 20.9 K (+90.32 %) |
| May 12 2021 | COLL | COLLEGIUM PHARMACE ... | Kuhlmann Shirley R. | EVP and General Cou ... | Sell | S | 22.77 | 7,000 | 159,390 | 89,990 | 97 K to 90 K (-7.22 %) |
| Apr 05 2021 | COLL | COLLEGIUM PHARMACE ... | Malamut Richard | EVP and Chief Medic ... | Payment of Exercise | F | 23.38 | 3,119 | 72,922 | 93,558 | 96.7 K to 93.6 K (-3.23 %) |
| Apr 05 2021 | COLL | COLLEGIUM PHARMACE ... | Fleming Alison B | EVP & Chief Technic ... | Payment of Exercise | F | 23.38 | 7,900 | 184,702 | 145,080 | 153 K to 145.1 K (-5.16 %) |
| Apr 05 2021 | COLL | COLLEGIUM PHARMACE ... | Fleming Alison B | EVP & Chief Technic ... | Payment of Exercise | F | 23.38 | 1,757 | 41,079 | 152,980 | 154.7 K to 153 K (-1.14 %) |
| Mar 18 2021 | COLL | COLLEGIUM PHARMACE ... | Kuhlmann Shirley R. | EVP and General Cou ... | Payment of Exercise | F | 24.69 | 734 | 18,122 | 96,990 | 97.7 K to 97 K (-0.75 %) |
| Mar 17 2021 | COLL | COLLEGIUM PHARMACE ... | Heffernan Michael Thomas | Director | Sell | S | 25.88 | 3,031 | 78,442 | 4,047 | 7.1 K to 4 K (-42.82 %) |
| Mar 17 2021 | COLL | COLLEGIUM PHARMACE ... | Heffernan Michael Thomas | Director | Sell | S | 25.26 | 47,044 | 1,188,331 | 7,078 | 54.1 K to 7.1 K (-86.92 %) |
| Mar 03 2021 | COLL | COLLEGIUM PHARMACE ... | Ciaffoni Joseph | President and CEO | Option Exercise | M | 8.22 | 48,616 | 399,624 | 16,205 | |
| Mar 03 2021 | COLL | COLLEGIUM PHARMACE ... | Ciaffoni Joseph | President and CEO | Sell | S | 23.30 | 9,809 | 228,550 | 278,307 | 288.1 K to 278.3 K (-3.40 %) |
| Mar 03 2021 | COLL | COLLEGIUM PHARMACE ... | Ciaffoni Joseph | President and CEO | Sell | S | 22.56 | 54,959 | 1,239,875 | 288,116 | 343.1 K to 288.1 K (-16.02 %) |
| Mar 03 2021 | COLL | COLLEGIUM PHARMACE ... | Ciaffoni Joseph | President and CEO | Buy | M | 8.22 | 48,616 | 399,624 | 343,075 | 294.5 K to 343.1 K (+16.51 %) |
| Mar 03 2021 | COLL | COLLEGIUM PHARMACE ... | Fleming Alison B | Chief Technical Off ... | Option Exercise | M | 3.31 | 1,449 | 4,796 | 0 | |
| Mar 03 2021 | COLL | COLLEGIUM PHARMACE ... | Fleming Alison B | Chief Technical Off ... | Option Exercise | M | 0.90 | 1,811 | 1,630 | 0 | |
| Mar 03 2021 | COLL | COLLEGIUM PHARMACE ... | Fleming Alison B | Chief Technical Off ... | Option Exercise | M | 0.90 | 64 | 58 | 0 |
View all COLLEGIUM PHARMACEUTICAL, INC insider transactions.